PLYMOUTH, Minn., Feb. 8 /PRNewswire-FirstCall/ -- ev3 Inc. will release its 2007 fourth quarter and full-year financial results on Friday, February 22, 2008, before regular market trading hours.
The company will host a conference call and webcast the same day at 7:30 a.m. CT (8:30 a.m. ET). ev3 management will review its fourth quarter and full-year financial and operating results and future outlook, followed by a question and answer session.
The conference call will be available to interested parties through a live audio webcast at http://www.ev3.net, where it will be archived and accessible for approximately 90 days. The live dial-in number for the call is 800-901-5231 (U.S.) or 617-786-2961 (International). The participant passcode is 91202727.
If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888 (International) and enter passcode 63034695. The audio replay will be available beginning at 10:00 a.m. CT on Friday, February 22, 2008 until Friday, February 29, 2008.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to improving the lives of patients with vascular disease through the development of innovative endovascular therapies. ev3’s products are used by endovascular specialists to treat a wide range of peripheral vascular and neurovascular diseases and disorders. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolic coils, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.
ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.
jtracy@ev3.net
CONTACT: Julie Tracy, Sr. Vice President, Chief Communications Officer of
ev3 Inc., +1-949-680-1375, jtracy@ev3.net
Web site: http://www.ev3.net/
